sleeping with one eye opened
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Highlights form latest conference call:
1)Revenues for our third quarter were a 15% increase over the third quarter last year. For the year-to-date 17% increase over the first nine months of 2015. Revenues are driven by our portfolio growth and our consolidated portfolio did increase 19% compared to a year ago.
2)Earnings per share of $0.26 for the quarter EPS - for the full year so far nine months $0.75
3) The competition - it is tough environment where you have a lot of small companies that sort of entered the market to take advantage of it a few years back. They are all struggling and even more importantly some of the very large companies in our industry are struggling. And so between that we sort of sit in the middle, Some guys have gone public and everybody wants to know what is going to happen there. So they sort of bypass us because we are already public, everything is going fine, and we actually make more money than lots of other folks.
4)This is probably the first time in 25 year history of the company where we are actually in a real good firm spot to sort of wait and see how the rest of it shapes up. So what is interesting and new it is sort of not a bad place to be.
5) We continue on our stock repurchase. We bought 421,000 shares this quarter and it is down a little from the 850,000 we bought the previous quarter. But we have now bought over 3 million shares, we will continue to buy it as often as we can.
6) good news is our book value as of today is now $7.54 a share that is versus $6 a year ago, give or take.
7)I think recession will show up, I don’t know if it is tomorrow but again we are very well prepared for it.
Note: current PPS only 5.16 (Eps cca 1.00, Book value 7.46)
If they sell, they have to pay a tax, it is better to sell in January, as we may see some correction in 2017. If you lock profit now and have to pay taxes in 2017 in the time of correction, you will be less happy, than if you have correction, but do not have to pay taxes from MTG gains...
Therefore I do not expect sell off until the beginning of January. I mean generally, not only for MTG. But we will see...
I was having IMH for some quarters but sold as I do not understand why they do not generate cash...but they are still on my watch list as I was supposing them to be at 30 instead of 15...
Anayway, I would appreciate to make some board with the same attitude investors, we will discuss the stocks there. this is MTG board...
what about here, guys?
http://investorshub.advfn.com/Bottom-Busters-Turnaround-Stories-Hot-Explorers-10002/
while MTG keeps to have biggest stake of my portfolio, I have increased position in CPSS and currently reconsidering SGM, which can be another over 100% gain monster. I will possibly buy initial position on Monday..
18 mil shares repurchase would mean 5% increase in book value.
That means another cca 38 cents per share.
plus there is +4,4% y/y increase in insurance in force
plus there is -19,7% y/y decrease in deliquent inventory.
By the other words..management has changed MTG in just 4,5 years from company close to bancruptcy into healthy strong cash cow.
PPS over 10 before Christmas? Possibly yes...
6.3 million women alive who had been diagnosed with breast cancer in the previous five years. That means market for plus minus 5 milions of women.
If enobosarm is used like ostarin 15-25 mg daily,(with current price 500mg = USD 90 source ) it can make revenues 90usd x 12 months= 1080 USD per treated person annualy. 5 million users x 1080 =5.4 billions. Number of O/S is 160 milions. That means 5400:160 = revenues 33.75 USD/ share.
If after reduction of all distribution and production costs will leave for GTX Inc only 10%..I mean only 10%. then it is 3.375 USD income per share. IF we calculate P/E only 5, then the stock price may reach 5 x 3.375 = 16,87 USD
So yes, if the result is clear success, the pps may reach 1687% if we consider 1 dollar as the base...
Sorry, I was bored so I have played with the numbers
Is it impolite to break three years of silence here?
BDI is up again...over 2%
Dry Bulk Shipping – The overweight on Dry Bulk is paying off handsomely (15 November 2016)
We have earlier advocated that “the normalization process will lead to great opportunities even with incremental gains in the underlying markets as discount to Net Asset Values narrow. With the market bottoming out, we place our bets on the dry bulk names with high operating leverage and considerable exposure to the spot market. We expect the uptrend in freight rates to mirror in asset prices, which in turn, will have an amplified effect on stock prices. For existing players and asset markets, valuations have very little downside in our view. Bankruptcy risk which was being priced across stocks has significantly eased as key players raised equity and continue to restructure debt and balance sheets. We expect freight markets to recover gradually in the remaining months of the year as Chinese stimulus flows through the industrial economy, providing opportunities to add exposure to dry bulk on correction as we believe the worst is behind us.” Apart from the normalisation trade, one key pillar of our thesis was the investor under ownership. We were rightly positioned since early summer on capturing the delta in stock prices as normalisation took hold. We see the left out feeling to be evident and expect investors to start giving a relook to the sector and dig deeper into the fundamentals and available opportunities. The start of the 3Q16 has seen further uptick in the dry bulk market with underlying stocks seeing a very strong momentum. At the end of last week, the BDI was above 1,000 for the first time in 15 months, Capesize rates inched above 17,000/day and most dry bulk stocks were been nearing their yearly highs. In our model portfolio, we had increased our weightage to Dry bulk shipping at 42% and Container shipping was least-weighted at the bottom with just 8%. With our negative thesis on the container shipping and AP Moller Maersk playing out well, our portfolio has been paying off handsomely. What next, we will continue to ride the rally in dry bulk stocks and even as we fell the best of the amplified gains could be behind us. However, we still expect the sector to clearly outperform the wider shipping investing landscape in coming quarters.
Source: Drewry Maritime Equity Research, Hellenic Shipping News Worldwide.
well, last time BDI Index has reached 1200, the stock spiked to 4.40. It was in the summer of 2015.
Now BDI Index is a bit higher than that time. And when BDI Index was at 1400 (October 2014) then the stock went up up to almost 6.00
My point is, that this time BDI Index can go again above 1400.
Interesting thing is, that it goes up together with stronger dollar. One would say, it should be just the opposite.
Or by other words...if the dollar is not as strong, then BDI Index would be now possibly far higher. Anyway, strong dollar and high BDI Index are both positive parametres for better Q4 results.
Unfortunately we will see now only Q3 results next week...
BDI INDEX IS OVER 1200 TODAY!!!
17 November 2016
Baltic Dry Index (BDI) +86 1231
52 weeks high is again higher, stock is heading to 3.00 without any doubts
I own 12k shares...and honestly, who cares about dividends if stock goes to 6.00 or higher...yes, it is nice but peanust.BDI Index makes this company veeeery undervalued.
at 2.10 PPS is the market cap of this company ONLY
Market Cap (intraday) 227.94M (yahoo finance source)
Revenue (ttm) 469.24M
Book Value 9.02 !!!
If they become profitable (and with BDI Index over 1000 they will be very profitable) then this is easily 3-4 bagger
It seems to be so evident, that I even do not expect too much volatility on the way there...
I have added 1000 shares at 8.51. Company is profitable, more and more new insurances written, number of deliquancies are still in free fall mode...9.18 is the wall to get over...then it goes over 10.
The president - elect is housing guru, I do not expect anything bad for housing industry in Trump era. Just the opposite...
Baltic Dry Index
BDIY:IND
1,065.00
20.00
1.91%
As of 7:57 AM EST 11/14/2016
Open
1,065.00
Day Range
1,065.00 - 1,065.00
Previous Close
1,045.00
52Wk Range
290.00 - 1,065.00
BDI Index is on 52 weeks high
BDIY:IND
1,045.00
71.00
7.29%
As of 8:03 AM EST 11/11/2016
Previous Close
974.00
52Wk Range
290.00 - 1,045.00
Time for McDermott to bag some juicy tender http://www.oilpubs.com/oso/category.asp?v1=6
yahoo finance is a dead tool. Welcome on investorhub, tommygun...any idea about some undervalued turnarounds? Except promissing but risky GTXI I have no stock where I expect over 100% gain.
MTG is currently 50% of my portfolio. I agree it might stop for a while under 9.20. But definitely not forever...stock is better and better shape every damn quarter.
Then I have MDR, BAC, BLDP, GTXI and CPSS...CPSS could outperform all but ist is currently my smallest holding.
Based on current BDI Index I thinking about some purchase of NM for Monday.
And I am actively trading GNW now. Only stock I am trading...
It is about BDI index and Trump euphoria..these data influence pps
This could be interesting for McDermott. In June they have announced cooperation with Shell in Brunei.
Those 10 billions...I guess at least 1/10 can be awarded to McDermott...if not more. I mean, companies usually keep their suppliers . Possibly therefor yesterday´s spike in PPS.
http://finance.yahoo.com/news/shell-rds-announces-plan-invest-122812871.html
peachman, I buy for few years only NYSE, NASDAQ stocks...not OTC or pinks
...peace
16:22 $ 4.0732 High 448
16:13 $ 4.0685 3,100
16:01 $ 4.01 Low 2,300
16:01 $ 4.02 2,092
16:01 $ 4.02 150
16:01 $ 4.02 132
Read more: http://www.nasdaq.com/symbol/gnw/after-hours#ixzz4On9YxuGf
what big blocks do you mean?
In connection with the termination of the merger agreement, the Company(GNW) may be required to pay Parent a termination fee of $105 million
https://www.sec.gov/Archives/edgar/data/1276520/000119312516744410/d275076d8k.htm
If you own good stock, than it is always better to hold. They do well. And they can anytime come with the news of another won tender...to chase the stock you have sold lower is usually depressing. Good luck with ALDW. I will watch it..
No idea, what do you mean...but good luck
Unfortunately you have no credit to say so. Unless you are regulator. And if you are regulator, then pls tell us when and if Anbang will receive approval for Fidelity insurance? It is already one year and no approval on the way, currently the applications is called off... http://www.reuters.com/article/us-fgl-m-a-anbanginsurance-idUSKCN0SY1G120151109
If the deal is clear, then pps is at 5.43 as Chinese would be buying everything from the market under one cent below 5.43.
But they are not buying.
In fact they will receive hundreds of miliions from GNW, if deal will be not approved. For those Chinese it is a win situation, if there is no regulatory approval
yes, but it can be bought simply from Chapter 11...and in that case shareholders are out of game. Anyway, I have now 47k to reinvest somewhere...
who talks here about Genworth? Yes, Genworth is screwed...but what penalty will be set on Chinese, if they back off? Nothing..only on Genworth, which is already burried.
I have a feeling, that all this info has been orchestrated, mutual funds and institutions agreed with Genworth and Chinese this deal to be announced, so that they can bail out with as less harm as possible..In last three days has been traded possibly 30% of total O/S...
Possibly I am wrong. But even the small probability that I can be wrong makes GNW to risky to buy...to gain 20% comparing to lose 100% is for me not a reasonable risk
I have one very costly experience from stock market. Never trust to anything Chinese...even if "audited".
I mean these guys do not respect any rules...if whatever can be broken for their own profit, they do it..
that is right..but to keep on having backlog, you need new tenders.. and they were anticipatig one or two other tenders to win...from those they were participating in...and nothing has happen. So I am happy about todays almost 5% move...the question is, if this earning moved the limit from 6 any further to higher levels.. and I think that not much..unless the backlog is higher than in the beginning of 2016
Earnings are not bad, positive is, that they are profitable. But it seems to me like by accounting cooked profit, On Revenues 500M you would expect from healthy company 10% profit. 2,5% is just cosmetic battle for result in black numbers.
I appreciate that, because enviroment is not excellent at the moment. The question is, if it stays like that for long. Then of course is the question, if such profit margins can attract wider group of investors.
Question for me is why they have not announced any other major contract since January I guess... They had really few tenders on the run. And possibly no major contract was awarded to Mc Dermott
you call nice profit to cash .99 on stock which has still tons of positive news to come? this is going to be more than ten bagger mate
GTx Achieves Stage 1 Milestone in Phase 2 Clinical Trial of Enobosarm in ER+/AR+ Breast Cancer
Date : 09/08/2016 @ 7:00AM
Source : Business Wire
Stock : Gtx, Inc. (MM) (GTXI)
Quote : 0.6737 0.0437 (6.94%) @ 9:34A
Today´s news is really "pot of gold" news. Well done, GTX Inc
WILLS ROBERT JAMES
Officer
Purchase at $0.65 per share. Direct 65,000 Jun 16, 2016 100,000
GLASS J KENNETH
Director
Purchase at $0.60 - $0.6 per share. Direct 26,000 Mar 1, 2016 44,000
HANOVER MARC STEVEN
Officer
Purchase at $0.65 - $0.65 per share. Direct 2,600 Jan 26, 2016 4,000
HANOVER MARC STEVEN
Officer
Purchase at $0.63 - $0.63 per share. Direct 8,072 Jan 25, 2016 12,813
HANOVER MARC STEVEN
Officer
Purchase at $0.50 - $0.5 per share. Direct 13,000 Jan 19, 2016 25,000
HANOVER MARC STEVEN
Officer
Purchase at $0.49 - $0.49 per share. Direct 11,000 Jan 15, 2016 22,100
HANOVER MARC STEVEN
Officer
Purchase at $0.47 - $0.47 per share. Direct 1,363 Jan 14, 2016 2,900
GLASS J KENNETH
Director
Purchase at $0.79 - $0.79 per share. Direct 79 Dec 24, 2015 100
GLASS J KENNETH
Director
Purchase at $0.79 - $0.79 per share. Direct 474 Dec 23, 2015 600
GLASS J KENNETH
Director
Purchase at $0.78 - $0.78 per share. Direct 1,019 Dec 22, 2015 1,307
GLASS J KENNETH
Director
Purchase at $0.78 - $0.78 per share. Direct 31,000 Dec 21, 2015 39,900
GLASS J KENNETH
Director
Purchase at $1.25 - $1.25 per share. Indirect 31,000 May 19, 2015 24,500
WILLS ROBERT JAMES
Officer
Purchase at $0.98 per share. Direct 35,711 May 14, 2015 36,440
WILLS ROBERT JAMES
Officer
Purchase at $0.88 - $0.88 per share. Direct 8,536 May 13, 2015 9,700
WILLS ROBERT JAMES
Officer
Purchase at $0.80 - $0.8 per share. Direct 3,088 May 11, 2015 3,860
DOGGRELL HENRY PATTON
Officer
Purchase at $0.80 - $0.8 per share. Indirect 20,000 May 8, 2015 25,477
WILLS ROBERT JAMES
Officer
Purchase at $0.80 - $0.8 per share. Direct 40,000 May 8, 2015 50,000
GLASS J KENNETH
Director
Purchase at $0.72 - $0.72 per share. Direct 7,200 Apr 22, 2015 10,000
GLASS J KENNETH
Director
Purchase at $0.71 - $0.71 per share. Direct 5,435 Apr 21, 2015 7,656
GLASS J KENNETH
Director
Purchase at $0.72 - $0.72 per share. Direct 2,845 Apr 20, 2015 3,952
GLASS J KENNETH
Director
Purchase at $0.72 - $0.72 per share. Direct 2,376 Apr 15, 2015 3,300
GLASS J KENNETH
Director
Purchase at $0.67 - $0.67 per share. Direct 11,000 Apr 10, 2015 16,400
Two many insiders were buying prior to appointment of Dr. Garry Neil. As stated, he has got a proven track record of turning new science into breakthrough commercial products. And in last conference call report from seeking alpha they stated :
1) enobosarm - we expect to have the results of Stage 1, which is the first 18 invaluable patients per each dose by yearend...We expect this data to be published later this year.
2) SARD - our compounds degrade the full length and variant forms of the androgen receptor. We hope to have several IND-ready compounds that could be taken into the clinic in 2017.
3) SUI - There are no orally available effective treatment options for SUI. We expect to have results from this trial in the second half of this year.
Addditonly they said...: we're optimistic that our ongoing efforts will allow us to achieve key data milestones across several programs in 2016.
It seems the time is starting to come. Why would they have appointed somebody, who helps to market the drugs, if they feel they have no drug to market?